JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB209795

Anti-NFkB p105 / p50 抗体

Anti-NFkB p105 / p50 antibody

Be the first to review this product! Submit a review

|

(6 Publications)

Rabbit Polyclonal NFkB p105 / p50 antibody. Suitable for IHC-P, ICC, WB and reacts with Human samples. Cited in 6 publications. Immunogen corresponding to Recombinant Fragment Protein within Human NFKB1 aa 350 to C-terminus.

別名を表示する

Nuclear factor NF-kappa-B p105 subunit, DNA-binding factor KBF1, EBP-1, Nuclear factor of kappa light polypeptide gene enhancer in B-cells 1, NFKB1

6 Images
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-NFkB p105 / p50 antibody (AB209795)
  • IHC-P

Supplier Data

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-NFkB p105 / p50 antibody (AB209795)

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) analysis of human colon tissue labelling NFkB p105 / p50 with ab209795 at 1/200 dilution. Heat mediated antigen retrieval performed with citrate buffer pH 6 before commencing with IHC staining protocol.

Immunocytochemistry - Anti-NFkB p105 / p50 antibody (AB209795)
  • ICC

Supplier Data

Immunocytochemistry - Anti-NFkB p105 / p50 antibody (AB209795)

Immunofluorescent analysis of A431 cells (PFA-fixed/Triton X-100 permeabilized) labeling NFkB p105 / p50 with ab209795 at 4 μg/ml (green).

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-NFkB p105 / p50 antibody (AB209795)
  • IHC-P

Supplier Data

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-NFkB p105 / p50 antibody (AB209795)

Immunohistochemical analysis of Paraffin-embedded Human lymph node tissue labeling NFkB p105 / p50 with ab209795 at 1/200 dilution.

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-NFkB p105 / p50 antibody (AB209795)
  • IHC-P

Supplier Data

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-NFkB p105 / p50 antibody (AB209795)

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) analysis of human urinary bladder tissue labelling NFkB p105 / p50 with ab209795 at 1/200 dilution. Heat mediated antigen retrieval performed with citrate buffer pH 6 before commencing with IHC staining protocol.

Western blot - Anti-NFkB p105 / p50 antibody (AB209795)
  • WB

Supplier Data

Western blot - Anti-NFkB p105 / p50 antibody (AB209795)

Loading control : Anti-GAPDH

All lanes:

Western blot - Anti-NFkB p105 / p50 antibody (ab209795) at 0.4 µg/mL

Lane 1:

SK-BR-3 (human mammary gland adenocarcinoma cell line) transfected with control siRNA, cell lysate

Lane 2:

SK-BR-3 transfected with target specific siRNA probe #1, cell lysate

Lane 3:

SK-BR-3 transfected with target specific siRNA probe #2, cell lysate

Predicted band size: 105 kDa

false

Western blot - Anti-NFkB p105 / p50 antibody (AB209795)
  • WB

Supplier Data

Western blot - Anti-NFkB p105 / p50 antibody (AB209795)

All lanes:

Western blot - Anti-NFkB p105 / p50 antibody (ab209795) at 0.4 µg/mL

All lanes:

Daudi (human Burkitt's lymphoma cell line) cell lysate

Predicted band size: 105 kDa

false

Key facts

宿主種

Rabbit

クローン性

Polyclonal

アイソタイプ

IgG

キャリアフリー

No

交差種

Human

アプリケーション

IHC-P, WB, ICC

applications

免疫原

Recombinant Fragment Protein within Human NFKB1 aa 350 to C-terminus. The exact immunogen used to generate this antibody is proprietary information.

P19838

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Species", "Dilution Info", "Notes"], "tabs": { "all-applications": {"fullname" : "All Applications", "shortname": "All Applications"}, "IHCP" : {"fullname" : "Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections)", "shortname":"IHC-P"}, "ICC" : {"fullname" : "Immunocytochemistry", "shortname":"ICC"}, "WB" : {"fullname" : "Western blot", "shortname":"WB"} }, "product-promise": { "all": "all", "testedAndGuaranteed": "tested", "guaranteed": "expected", "predicted": "predicted", "notRecommended": "not-recommended" } }, "values": { "Human": { "IHCP-species-checked": "testedAndGuaranteed", "IHCP-species-dilution-info": "1/200 - 1/500", "IHCP-species-notes": "<p></p> Perform heat-mediated antigen retrieval with citrate buffer pH 6 before commencing with IHC staining protocol.", "ICC-species-checked": "testedAndGuaranteed", "ICC-species-dilution-info": "0.25-2 µg/mL", "ICC-species-notes": "<p></p>", "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "0.04-0.4 µg/mL", "WB-species-notes": "<p></p>" } } }

出荷温度及び保存条件

製品の状態
Liquid
精製方法
Affinity purification Immunogen
バッファー組成
pH: 7.2 Preservative: 0.02% Sodium azide Constituents: PBS, 40% Glycerol (glycerin, glycerine)
出荷温度
Blue Ice
短期保存期間
1-2 weeks
短期保存温度
+4°C
長期保存温度
-20°C
分注に関する情報
Upon delivery aliquot
保管に関する情報
Avoid freeze / thaw cycle

製品プロトコール

For this product, it's our understanding that no specific protocols are required. You can visit:

ターゲットの情報

NF-kappa-B is a pleiotropic transcription factor present in almost all cell types and is the endpoint of a series of signal transduction events that are initiated by a vast array of stimuli related to many biological processes such as inflammation, immunity, differentiation, cell growth, tumorigenesis and apoptosis. NF-kappa-B is a homo- or heterodimeric complex formed by the Rel-like domain-containing proteins RELA/p65, RELB, NFKB1/p105, NFKB1/p50, REL and NFKB2/p52 and the heterodimeric p65-p50 complex appears to be most abundant one. The dimers bind at kappa-B sites in the DNA of their target genes and the individual dimers have distinct preferences for different kappa-B sites that they can bind with distinguishable affinity and specificity. Different dimer combinations act as transcriptional activators or repressors, respectively. NF-kappa-B is controlled by various mechanisms of post-translational modification and subcellular compartmentalization as well as by interactions with other cofactors or corepressors. NF-kappa-B complexes are held in the cytoplasm in an inactive state complexed with members of the NF-kappa-B inhibitor (I-kappa-B) family. In a conventional activation pathway, I-kappa-B is phosphorylated by I-kappa-B kinases (IKKs) in response to different activators, subsequently degraded thus liberating the active NF-kappa-B complex which translocates to the nucleus. NF-kappa-B heterodimeric p65-p50 and RelB-p50 complexes are transcriptional activators. The NF-kappa-B p50-p50 homodimer is a transcriptional repressor, but can act as a transcriptional activator when associated with BCL3. NFKB1 appears to have dual functions such as cytoplasmic retention of attached NF-kappa-B proteins by p105 and generation of p50 by a cotranslational processing. The proteasome-mediated process ensures the production of both p50 and p105 and preserves their independent function, although processing of NFKB1/p105 also appears to occur post-translationally. p50 binds to the kappa-B consensus sequence 5'-GGRNNYYCC-3', located in the enhancer region of genes involved in immune response and acute phase reactions. In a complex with MAP3K8, NFKB1/p105 represses MAP3K8-induced MAPK signaling; active MAP3K8 is released by proteasome-dependent degradation of NFKB1/p105.. Nuclear factor NF-kappa-B p105 subunit. P105 is the precursor of the active p50 subunit (Nuclear factor NF-kappa-B p50 subunit) of the nuclear factor NF-kappa-B (PubMed : 1423592). Acts as a cytoplasmic retention of attached NF-kappa-B proteins by p105 (PubMed : 1423592).. Nuclear factor NF-kappa-B p50 subunit. Constitutes the active form, which associates with RELA/p65 to form the NF-kappa-B p65-p50 complex to form a transcription factor (PubMed : 1740106, PubMed : 7830764). Together with RELA/p65, binds to the kappa-B consensus sequence 5'-GGRNNYYCC-3', located in the enhancer region of genes involved in immune response and acute phase reactions (PubMed : 1740106, PubMed : 7830764).
See full target information NFKB1

文献 (6)

Recent publications for all applications. Explore the full list and refine your search

Cell death & disease 13:863 PubMed36220838

2022

Neddylation-mediated degradation of hnRNPA2B1 contributes to hypertriglyceridemia pancreatitis.

Applications

Unspecified application

Species

Unspecified reactive species

Wei Chen,Yilong Wang,Wenwen Xia,Jinbao Zhang,Yan Zhao

Evidence-based complementary and alternative medicine : eCAM 2021:9943692 PubMed34557256

2021

Study on the Mechanism of Qigu Capsule in Upregulating NF-B/HIF-1 Pathway to Improve the Quality of Bone Callus in Mice at Different Stages of Osteoporotic Fracture Healing.

Applications

Unspecified application

Species

Unspecified reactive species

Peige Wang,Jie Ding,Guangyue Yang,Wen Sun,Hailing Guo,Yongfang Zhao

Advances in clinical and experimental medicine : official organ Wroclaw Medical University 30:673-679 PubMed34118145

2021

Investigating the inflammatory cascade effect of basophil activation in children with allergic rhinitis or asthma, via the IgE-FcεRI-NF-κB signaling pathway.

Applications

Unspecified application

Species

Unspecified reactive species

Yi Qiao,Jie Chen

Frontiers in oncology 10:548744 PubMed33344225

2020

Development and Validation of Nomograms Based on Gamma-Glutamyl Transpeptidase to Platelet Ratio for Hepatocellular Carcinoma Patients Reveal Novel Prognostic Value and the Ratio Is Negatively Correlated With P38MAPK Expression.

Applications

Unspecified application

Species

Unspecified reactive species

Dingan Luo,Haoran Li,Jie Hu,Mao Zhang,Shun Zhang,Liqun Wu,Bing Han

Cancer management and research 11:10623-10632 PubMed31908534

2019

High Inflammatory Factor Grading Predicts Poor Disease-Free Survival in AJCC Stage I-II Hepatocellular Carcinoma Patients After R0 Resection.

Applications

Unspecified application

Species

Unspecified reactive species

Mao Zhang,Mei-Sze Chua,Jie Hu,Haoran Li,Shun Zhang,Liqun Wu,Bing Han

International journal of molecular sciences 19: PubMed30004416

2018

The Olive Biophenols Oleuropein and Hydroxytyrosol Selectively Reduce Proliferation, Influence the Cell Cycle, and Induce Apoptosis in Pancreatic Cancer Cells.

Applications

Unspecified application

Species

Unspecified reactive species

Chloe D Goldsmith,Danielle R Bond,Helen Jankowski,Judith Weidenhofer,Costas E Stathopoulos,Paul D Roach,Christopher J Scarlett
View all publications

Abcam product promise

当社は、高品質な試薬を通じてお客様の研究を力強くサポートすることをお約束いたします。ご使用いただく各段階で、常にお客様をサポートできる体制を整えております。万が一、製品が期待通りに機能しない場合は、「Abcam Product Promise」による当社保証制度に基づき、安心してご利用いただけます。
保証に関する詳細については利用規約をご確認ください。

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com